Dickson Data is back at it. On Thursday it released a new infographic [below] showing which drug patents are set to expire in 2017.
It follows the template of its popular 2016 infographic, which highlighted several major biopharma threats and trends. Times were tough for AstraZeneca, which had $7.4 billion in sales under threat as Crestor and Seroquel XR lose patent exclusivity.